Cargando…
Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
BACKGROUND: The question of how to set the cost-effectiveness threshold for new, innovative medicines is a matter of ongoing controversy. One prominent proposal suggests that the cost-effectiveness threshold adopted by the U.K. National Institute for Health and Care Excellence (NICE) should represen...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178559/ https://www.ncbi.nlm.nih.gov/pubmed/32321496 http://dx.doi.org/10.1186/s12913-020-5050-9 |